Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Issue 12 (11th October 2017)

• Record Type: Journal Article
• Authors: Caimmi, D.; Baiz, N.; Tanno, L. K.; Demoly, P.; Arnavielhe, S.; Murray, R.; Bedbrook, A.; Bergmann, K. C.; De Vries, G.; Fokkens, W. J.; Fonseca, J.; Haahtela, T.; Keil, T.; Kuna, P.; Mullol, J.; Papadopoulos, N.; Passalacqua, G.; Samolinski, B.; Tomazic, P. V.; Valiulis, A.; van Eerd, M.; Wickman, M.; Annesi‐Maesano, I.; Bousquet, J.
• Other Names: Agache I investigator.; Angles R investigator.; Anto JM investigator.; Asayag E investigator.; Bacci E investigator.; Bachert C investigator.; Baroni I investigator.; Barreto BA investigator.; Bedolla‐Barajas M investigator.; Bertorello L investigator.; Bewick M investigator.; Bieber T investigator.; Birov S investigator.; Bindslev‐Jensen C investigator.; Blua A investigator.; Bochenska Marciniak M investigator.; Bogus‐Buczynska I investigator.; Bosnic‐Ancevich S investigator.; Bosse I investigator.; Bourret R investigator.; Bucca C investigator.; Buonaiuto R investigator.; Caiazza D investigator.; Caillot D investigator.; Caimmi DP investigator.; Camargos P investigator.; Canfora G investigator.; Cardona V investigator.; Carriazo AM investigator.; Cartier C investigator.; Castellano G investigator.; Chavannes NH investigator.; Ciaravolo MM investigator.; Cingi C investigator.; Ciceran A investigator.; Colas L investigator.; Colgan E investigator.; Coll J investigator.; Conforti D investigator.; Correira de Sousa J investigator.; Cortés‐Grimaldo RM investigator.; Corti F investigator.; Costa E investigator.; Courbis AL investigator.; Cruz A investigator.; Custovic A investigator.; Dario C investigator.; da Silva M investigator.; Dauvilliers Y investigator.; De Blay F investigator.; Dedeu T investigator.; De Feo G investigator.; De Martino B investigator.; Di Capua S investigator.; Di Carluccio N investigator.; Dray G investigator.; Dubakiene R investigator.; Eller E investigator.; Emuzyte R investigator.; Espinoza‐Contreras JM investigator.; Estrada‐Cardona A investigator.; Farrell J investigator.; Ferrero J investigator.; Fontaine JF investigator.; Forti S investigator.; Gálvez‐Romero JL investigator.; Garcia Cruz MH investigator.; García‐Cobas CI investigator.; Gemicioğlu B investigator.; Gerth van Wijck R investigator.; Guidacci M investigator.; Gómez‐Vera J investigator.; Guldemond NA investigator.; Gutter Z investigator.; Hajjam J investigator.; Hellings P investigator.; Hernández‐Velázquez L investigator.; Illario M investigator.; Ivancevich JC investigator.; Jares E investigator.; Joos G investigator.; Just J investigator.; Kalayci O investigator.; Kalyoncu AF investigator.; Karjalainen J investigator.; Khaltaev N investigator.; Klimek L investigator.; Kull I investigator.; Kuna TP investigator.; Kvedariene V investigator.; Kolek V investigator.; Krzych‐Fałta E investigator.; Kupczyk M investigator.; Lacwik P investigator.; Larenas‐Linnemann D investigator.; Laune D investigator.; Lauri D investigator.; Lavrut J investigator.; Lessa M investigator.; Levato G investigator.; Lewis L investigator.; Lieten I investigator.; Lipiec A investigator.; Louis R investigator.; Luna‐Pech JA investigator.; Magnan A investigator.; Malva J investigator.; Maspero JF investigator.; Mayora O investigator.; Medina‐Ávalos MA investigator.; Melen E investigator.; Menditto E investigator.; Millot‐Keurinck J investigator.; Moda G investigator.; Morais‐Almeida M investigator.; Mösges R investigator.; Mota‐Pinto A investigator.; Muraro A investigator.; Noguès M investigator.; Nalin M investigator.; Napoli L investigator.; Neffen H investigator.; O'Hehir R investigator.; Olivé Elias M investigator.; Onorato G investigator.; Palkonen S investigator.; Pépin JL investigator.; Pereira AM investigator.; Persico M investigator.; Pfaar O investigator.; Pozzi AC investigator.; Prokopakis EP investigator.; Raciborski F investigator.; Rizzo JA investigator.; Robalo‐Cordeiro C investigator.; Rodríguez‐González M investigator.; Rolla G investigator.; Roller‐Wirnsberger RE investigator.; Romano A investigator.; Romano M investigator.; Salimäki J investigator.; Serpa FS investigator.; Shamai S investigator.; Sierra M investigator.; Sova M investigator.; Sorlini M investigator.; Stellato C investigator.; Stelmach R investigator.; Strandberg T investigator.; Stroetman V investigator.; Stukas R investigator.; Szylling A investigator.; Tibaldi V investigator.; Todo‐Bom A investigator.; Toppila‐Salmi S investigator.; Tomazic P investigator.; Trama U investigator.; Triggiani M investigator.; Valero A investigator.; Valovirta E investigator.; van Eerd M investigator.; Vasankari T investigator.; Vatrella A investigator.; Ventura MT investigator.; Verissimo MT investigator.; Viart F investigator.; Williams S investigator.; Wagenmann M investigator.; Wanscher C investigator.; Westman M investigator.; Young I investigator.; Yorgancioglu A investigator.; Zernotti E investigator.; Zurbierber T investigator.; Zurkuhlen A investigator.; De Oliviera B investigator.; Senn A investigator.;
• Is Part Of: Clinical & experimental allergy. Volume 47:Issue 12(2017)
• Page Start: 1526
• Page End: 1533
• Publication Date: 2017-10-11
• Subjects: allergic rhinitis -- allergy -- control -- MASK -- visual analogue scale; Allergy -- Periodicals; Immunology -- Periodicals; 616.97
• DOI: 10.1111/cea.13025
• Languages: English
• ISSNs: 0954-7894

Abstract

Summary: Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK‐rhinitis (MACVIA‐ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test‐retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK‐Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test‐retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK‐rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level.